Filing Details
- Accession Number:
- 0000930413-11-001492
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-03-01 16:10:02
- Reporting Period:
- 2011-02-28
- Filing Date:
- 2011-03-01
- Accepted Time:
- 2011-03-01 16:10:02
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 727510 | Enzon Pharmaceuticals Inc | ENZN | Biological Products, (No Disgnostic Substances) (2836) | 222372868 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1496873 | L Mark Ogden | C/O Enzon Pharamceuticals, Inc. 685 Route 202/206 Bridgewater NJ 08807 | Acting Vp Of Fin & Prin Fo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-02-28 | 2,000 | $10.65 | 4,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
